Lantern Pharma (LTRN.BOATS) Q2 2026 Earnings

15MayConfirmed
Q4 2025
Q2 2026
-0.47
-0.41
-0.36
-0.3

Details

Expected EPS
-0.36
Actual EPS
-0.3
Surprise EPS
0.06
Surprise Percent
+16.67%

Description

Lantern Pharma (LTRN.BOATS) has reported earnings of -0.3 per share for Q2 2026.

0 Comments

Share your thoughts